By Cara Bayles ( April 17, 2017, 10:21 PM EDT) -- Prosecutors for Orange County, California, have sued four drug companies over an anti-competitive scheme, alleging Boehringer Ingelheim Pharmaceuticals Inc. paid its rival more than $120 million not to create an inexpensive, generic version of the stroke prevention medication Aggrenox, in violation of state unfair competition laws....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.